METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE IN ELDERLY PATIENTS ATTENDING MILITARY HOSPITAL 175

Văn Tân Nguyễn, Hoà Bình Phạm, Long Triêu Đăng, Đình Hưng Cao

Main Article Content

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the elderly and is closely associated with metabolic syndrome. The coexistence of these two conditions not only increases the risk of liver disease progression but also raises the incidence of cardiovascular events and overall mortality. Objective: To investigate the prevalence of insulin resistance and its association with NAFLD in patients aged ≥ 60 years. Method: A cross-sectional study was conducted on 404 patients aged ≥ 60 years who visited the Senior Officials Clinic at Military Hospital 175 from August 2024 to June 2025. Result: The prevalence of metabolic syndrome was 46.3%, significantly higher in the NAFLD group compared to those without NAFLD (66.4% vs. 24.1%; p < 0.001), and increased progressively with disease severity. Components such as hyperglycemia, elevated triglycerides, low HDL-c, and central obesity were more common in the NAFLD group. Moreover, metabolic indices such as fasting glucose, HbA1c, and triglycerides tended to increase, while HDL-c decreased, in accordance with NAFLD severity. Conclusion: Metabolic syndrome is strongly associated with NAFLD in elderly patients. Early detection and management of its components are essential strategies in preventing and managing NAFLD in this population.

Article Details

References

Cao Thanh Ngọc, Ngô Tuấn Anh, Khoa Bùi Đăng (2023), "Mối liên quan giữa hội chứng chuyển hóa và loãng xương ở người cao tuổi". Tạp chí Y học Việt Nam, 522 (2), pp. 113-117.
2. Consultation WHO Expert (2004), "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies". Lancet, 363 (9403), pp. 157-63.
3. Pitisuttithum P., Chan W. K., Piyachaturawat P., Imajo K., Nakajima A., et al. (2020), "Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study". BMC Gastroenterol, 20 (1), pp. 88.
4. Radu F., Potcovaru C. G., Salmen T., Filip P. V., Pop C., et al. (2023), "The Link between NAFLD and Metabolic Syndrome". Diagnostics (Basel), 13 (4).
5. Staff Alcohol Research: Current Reviews Editorial (2018), "Drinking Patterns and Their Definitions". Alcohol Res, 39 (1), pp. 17-18.
6. Tallarico V., Recinella G., Magalotti D., Muscari A., Zoli M., et al. (2020), "Prognostic value of non-alcoholic fatty liver disease in the elderly patients". Aging Clin Exp Res, 32 (12), pp. 2657-2665.
7. Chen Tsung-Po, Lai Michelle, Lin Wen-Yuan, Huang Kuo-Chin, Yang Kuen-Cheh (2020), "Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: A community-based study". Journal of Gastroenterology and Hepatology, 35 (9), pp. 1636-1643.
8. Koehler Edith M., Schouten Jeoffrey N. L., Hansen Bettina E., van Rooij Frank J. A., Hofman Albert, et al. (2012), "Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study". Journal of Hepatology, 57 (6), pp. 1305-1311.